Alzheimer’s disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement

References

• Doulberis M, Kotronis G, Thomann R, et al. Impact of Helicobacter pylori on Alzheimer’s disease: what do we know so far?. Helicobacter. 2018;23(1):e12454.
   Web of Science ®Google Scholar
• Jiang C, Li G, Huang P, et al. The gut microbiota and Alzheimer’s disease. JAD. 2017;58(1):1–15.
   PubMed Web of Science ®Google Scholar
• Hu X, Wang T, Jin F. Alzheimer’s disease and gut microbiota. Sci China Life Sci. 2016;59(10):1006–1023.
   PubMed Web of Science ®Google Scholar
• Pistollato F, Cano SS, Elio I, et al. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev. 2016;74(10):624–634.
   PubMed Web of Science ®Google Scholar
• Mahaman YAR, Huang F, Henok KA, et al. Involvement of calpain in the neuropathogenesis of Alzheimer’s disease. Med Res Rev. 2019;39(2):608–630.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Bai F. The association of tau with mitochondrial dysfunction in Alzheimer’s disease. Front Neurosci. 2018;12:163.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Polyzos SA, Deretzi G. Multiple bi-directionality brain–gut interactions in patients with inflammatory bowel disease. Gastroenterology. 2018;155(5):1651–1652.
   PubMed Web of Science ®Google Scholar
• Carabotti M, Scirocco A, Maselli MA, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol Q Publ Hell Soc Gastroenterol. 2015;28:203–209.
   Google Scholar
• Kountouras J, Boziki M, Polyzos SA, et al. The emerging role of helicobacter pylori-induced metabolic gastrointestinal dysmotility and neurodegeneration. Curr Mol Med. 2017;17(6):389–404.
   PubMed Web of Science ®Google Scholar
• Alkasir R, Li J, Li X, et al. Human gut microbiota: the links with dementia development. Protein Cell. 2017;8(2):90–102.
   PubMed Web of Science ®Google Scholar
• Sochocka M, Donskow-Łysoniewska K, Diniz BS, et al. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review. Mol Neurobiol. 2019;56(3):1841–1851.
   PubMed Web of Science ®Google Scholar
• Spielman LJ, Gibson DL, Klegeris A. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Neurochem Int. 2018;120:149–163.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Wozniak MA, Appelt DM, et al. Infiltration of the brain by pathogens causes Alzheimer’s disease. Neurobiol Aging. 2004;25(5):619–627.
   PubMed Web of Science ®Google Scholar
• Dando SJ, Mackay-Sim A, Norton R, et al. Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev. 2014;27(4):691–726.
   PubMed Web of Science ®Google Scholar
• Sommer A, Winner B, Prots I. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases. Mol Neurodegener. 2017;12(1):1–10.
   PubMed Web of Science ®Google Scholar
• Bawa M, Saraswat VA. Gut-liver axis: role of inflammasomes. J Clin Exp Hepatol. 2013;3(2):141–149.
   PubMedGoogle Scholar
• Kountouras J, Deretzi G, Gavalas E, et al. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders. Med Hypotheses. 2014;82(3):368–373.
   PubMed Web of Science ®Google Scholar
• Bruno G, Rocco G, Zaccari P, et al. Helicobacter pylori infection and gastric dysbiosis: can probiotics administration be useful to treat this condition? J Can Des Mal Infect La Microbiol Medicale [Can J Infect Dis Med Microbiol]. 2018;2018:6237239.
   Google Scholar
• Dash NR, Khoder G, Nada AM, et al. Exploring the impact of Helicobacter pylori on gut microbiome composition. PLoS ONE. 2019;14(6):e0218274.
   PubMed Web of Science ®Google Scholar
• Budzyński J. Brain-gut axis in the pathogenesis of Helicobacter pylori infection. WJG. 2014;20(18):5212–5225.
   PubMed Web of Science ®Google Scholar
• Ticinesi A, Tana C, Nouvenne A, et al. Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. CIA. 2018;13:1497–1511.
   Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• Becker LA. Oa Overview of reviews In: Jpt H, Green S, editors. Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]. Cochrane Collab 2011. pp.1–21.
   Google Scholar
• Li J, Perez-Perez GI. Helicobacter pylori the Latent Human Pathogen or an Ancestral Commensal Organism. Front Microbiol. 2018;9:609.
   PubMed Web of Science ®Google Scholar
• Karin M, Clevers H. Reparative inflammation takes charge of tissue regeneration. Nature. 2016;529(7586):307–315.
   PubMed Web of Science ®Google Scholar
• de J R De-Paula V, Forlenza AS, Forlenza OV. Relevance of gutmicrobiota in cognition, behaviour and Alzheimer’s disease. Pharmacol Res. 2018;136:29–34.
   PubMed Web of Science ®Google Scholar
• Veronese N, Solmi M, Basso C, et al. Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease: a narrative review. Int J Geriatr Psychiatry. 2019;34(9):1316–1325.
   PubMed Web of Science ®Google Scholar
• Zhu M, Wang X, Sun L, et al. Can inflammation be resolved in Alzheimer’s disease?. Ther Adv Neurol Disord. 2018;11:175628641879110.
   Web of Science ®Google Scholar
• McManus RM, Heneka MT. Role of neuroinflammation in neurodegeneration: new insights. Alzheimers Res Ther. 2017;9(1):1–7.
   PubMed Web of Science ®Google Scholar
• Pritchard AB, Crean S, Olsen I, et al. Microbiomes and their role in Alzheimer’s disease. Front Aging Neurosci. 2017;1–10.
   Google Scholar
• Beydoun MA, Beydoun HA, Shroff MR, Kitner-Triolo MH, et al. Helicobacter pylori seropositivity and cognitive performance among US adults. Psychosom Med. 2013;75(5):486–496.
   PubMed Web of Science ®Google Scholar
• Katan M, Moon YP, Paik MC, et al. Infectious burden and cognitive function: the Northern Manhattan Study. Neurology. 2013;80(13):1209–1215.
   PubMed Web of Science ®Google Scholar
• Roubaud Baudron C, Letenneur L, Langlais A, Buissonnière A, Mégraud F, Dartigues J-F, et al. Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agées QUID Study. J Am Geriatr Soc. 2013;61(1):74–78.
   PubMed Web of Science ®Google Scholar
• Noble JM, Scarmeas N, Celenti RS, et al. Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease. PLoS One. 2014;9(12):e114959–14.
   PubMed Web of Science ®Google Scholar
• Andreadou E, Pantazaki AA, Daniilidou M, et al. Rhamnolipids, microbial virulence factors, in Alzheimer’s disease. JAD. 2017;59(1):209–222.
   Web of Science ®Google Scholar
• Bu X-L, Yao X-Q, Jiao S-S, et al. A study on the association between infectious burden and Alzheimer’s disease. Eur J Neurol. 2015;22(12):1519–1525.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Cattane N, Galluzzi S, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–68.
   PubMed Web of Science ®Google Scholar
• Ide M, Harris M, Stevens A, et al. Periodontitis and cognitive decline in Alzheimer’s disease. PLoS ONE. 2016;11(3):e0151081–9.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Boziki M, Gavalas E, et al. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol. 2010;23(3):199–204.
   PubMed Web of Science ®Google Scholar
• Malaguarnera M, Bella R, Alagona G, et al. Helicobacter pylori and Alzheimer’s disease: a possible link. Eur J Intern Med. 2004;15(6):381–386.
   PubMedGoogle Scholar
• Sparks Stein P, Steffen MJ, Smith C, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease. Alzheimers Dement. 2012;8(3):196–203.
   PubMed Web of Science ®Google Scholar
• Zhan X, Stamova B, Jin L-W, et al. Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology. 2016;87(22):2324–2332.
   PubMed Web of Science ®Google Scholar
• Farhad SZ, Amini S, Khalilian A, et al. The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease. Dent Res J (Isfahan). 2014;11(5):549–552.
   PubMedGoogle Scholar
• Cai W, Shen W-D. Anti-Apoptotic Mechanisms of Acupuncture in Neurological Diseases: A Review. Am J Chin Med. 2018;46(3):515–535.
   PubMed Web of Science ®Google Scholar
• Westfall S, Lomis N, Kahouli I, et al. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci. 2017;74(20):3769–3787.
   PubMed Web of Science ®Google Scholar
• Lapresa R, Agulla J, Sánchez-Morán I, et al. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization. Neuropharmacology. 2019;146:19–27.
   PubMed Web of Science ®Google Scholar
• Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J. 2015;282(21):4067–4079.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhu H, Zhang L, et al. The intestinal microbiome and Alzheimer’s disease: A review. Anim Model Exp Med. 2018;1(3):180–188.
   PubMedGoogle Scholar
• Sloop G, Weidman JJ, St. Cyr JA. Atherothrombosis is a Thrombotic, not Inflammatory Disease. Cureus. 2017;9(12):e1909.
   PubMed Web of Science ®Google Scholar
• Pugazhenthi S. Metabolic syndrome and the cellular phase of Alzheimer's disease. Prog Mol Biol Transl Sci.. 2017;146:243–258.
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Alzheimer disease as a vascular disorder. Stroke. 2002;33(4):1152–1162.
   PubMed Web of Science ®Google Scholar
• Xiang J. Carotid atherosclerosis promotes the progression of Alzheimer’s disease: a three-year prospective study. Exp Ther Med. 2017;14(2):1321–1326.
   PubMed Web of Science ®Google Scholar
• Hughes TM, Wagenknecht LE, Craft S, et al. Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study. Neurology. 2018;90(14):e1248–56.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Tsolaki M, Boziki M, et al. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol. 2007;14(9):976–982.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Tsolaki M, Gavalas E, et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006;66(6):938–940.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Boziki M, Gavalas E, et al. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer’s disease. Int J Neurosci. 2009;119(6):765–777.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Boziki M, Gavalas E, et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease. J Neurol. 2009;256(5):758–767.
   PubMed Web of Science ®Google Scholar
• Azad MAK, Huang P, Liu G, et al. Hyperhomocysteinemia and cardiovascular disease in animal model. Amino Acids. 2018;50(1):3–9.
   PubMed Web of Science ®Google Scholar
• Catena C, Colussi G, Nait F, et al. Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients. Am J Hypertens. 2015;28(7):943–950.
   PubMed Web of Science ®Google Scholar
• Roubaud-Baudron C, Krolak-Salmon P, Quadrio I, et al. Impact of chronic Helicobacter pylori infection on Alzheimer’s disease: preliminary results. Neurobiol Aging. 2012;33(5):1009.e11–9.
   PubMed Web of Science ®Google Scholar
• Benavides-Ward A, Vasquez-Achaya F, Silva-Caso W, et al. Helicobacter pylori and its relationship with variations of gut microbiota in asymptomatic children between 6 and 12 years. BMC Res Notes. 2018;11(1):468.
   PubMedGoogle Scholar
• Akbari E, Asemi Z, D, Kakhaki R, et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci. 2016;1–8.
   Web of Science ®Google Scholar
• Roubaud-Baudron C, Panhard X, Krolak-Salmon P, et al. Change of the dependent variable. Neurobiol Aging. 2013;34(6):e1.
   PubMed Web of Science ®Google Scholar
• Araos R, Andreatos N, Ugalde J, et al. Fecal microbiome among nursing home residents with advanced dementia and clostridium difficile. Dig Dis Sci. 2018;63(6):1525–1531.
   PubMed Web of Science ®Google Scholar
• Meer-Scherrer L, Chang Loa C, Adelson ME, et al. Lyme disease associated with Alzheimer’s disease. Curr Microbiol. 2006;52(4):330–332.
   PubMed Web of Science ®Google Scholar
• Minter MR, Zhang C, Leone V, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci Rep. 2016;6(1):30028.
   PubMed Web of Science ®Google Scholar
• Zhuang Z-Q, Shen L-L, Li W-W, et al. Gut Microbiota is Altered in Patients with Alzheimer’s Disease. JAD. 2018;63(4):1337–1346.
   Web of Science ®Google Scholar
• Syeda T, Sanchez-Tapia M, Pinedo-Vargas L, et al. Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer’s Disease. JAD. 2018;66(4):1657–1682.
   Web of Science ®Google Scholar
• Kong Y, Jiang B, Luo X. Gut microbiota influences Alzheimer’s disease pathogenesis by regulating acetate in Drosophila model. Future Microbiol. 2018;13(10):1117–1128.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Xiayu X, et al. Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease. JAD. 2017;60(4):1241–1257.
   Web of Science ®Google Scholar
• Shiota S, Murakami K, Yoshiiwa A, et al. The relationship between Helicobacter pylori infection and Alzheimer’s disease in Japan. J Neurol. 2011;258(8):1460–1463.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Zavos C, Boziki M, et al. Association between Helicobacter pylori infection and Alzheimer’s disease in Japan. J Neurol. 2011;258(11):2086–2086.
   PubMed Web of Science ®Google Scholar
• Nägga K, Rajani R, Mårdh E, et al. Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia. Dement Geriatr Cogn Disord. 2003;16(4):269–275.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Gavalas E, Zavos C, et al. Alzheimer’s disease and Helicobacter pylori infection: Defective immune regulation and apoptosis as proposed common links. Med Hypotheses. 2007;68(2):378–388.
   PubMed Web of Science ®Google Scholar
• Mahami-Oskouei M, Hamidi F, Talebi M, et al. Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?. Parasitol Res. 2016;115(8):3169–3174.
   PubMed Web of Science ®Google Scholar